Jefferies Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.31M | Buy |
+37,506
| New | +$2.37M | 0.02% | 555 |
|
|
2022
Q2 | – | Sell |
-32,448
| Closed | -$1.93M | – | 1657 |
|
|
2022
Q1 | $1.93M | Sell |
32,448
-379,863
| -92% | -$24.3M | 0.01% | 701 |
|
|
2021
Q4 | $29.9M | Buy |
412,311
+152,769
| +59% | +$10.5M | 0.18% | 93 |
|
|
2021
Q3 | $18.1M | Buy |
259,542
+65,352
| +34% | +$4.59M | 0.13% | 138 |
|
|
2021
Q2 | $13.4M | Buy |
194,190
+52,384
| +37% | +$3.5M | 0.08% | 202 |
|
|
2021
Q1 | $9.16M | Sell |
141,806
-54,692
| -28% | -$3.53M | 0.08% | 213 |
|
|
2020
Q4 | $11.4M | Sell |
196,498
-28,375
| -13% | -$1.71M | 0.09% | 191 |
|
|
2020
Q3 | $14.2M | Sell |
224,873
-19,188
| -8% | -$1.33M | 0.16% | 91 |
|
|
2020
Q2 | $18.8K | Buy |
244,061
+72,392
| +42% | +$5.55M | 0.22% | 59 |
|
|
2020
Q1 | $12.8M | Sell |
171,669
-148,659
| -46% | -$10.3M | 0.14% | 118 |
|
|
2019
Q4 | $20.8M | Buy |
320,328
+127,515
| +66% | +$8.3M | 0.16% | 108 |
|
|
2019
Q3 | $12.2M | Buy |
192,813
+7,565
| +4% | +$495K | 0.09% | 165 |
|
|
2019
Q2 | $12.5M | Buy |
185,248
+125,668
| +211% | +$8.27M | 0.09% | 177 |
|
|
2019
Q1 | $3.87M | Sell |
59,580
-124,303
| -68% | -$8.26M | 0.03% | 551 |
|
|
2018
Q4 | $11.5M | Buy |
183,883
+108,185
| +143% | +$7.56M | 0.09% | 169 |
|
|
2018
Q3 | $5.84M | Buy |
75,698
+31,010
| +69% | +$2.34M | 0.04% | 472 |
|
|
2018
Q2 | $3.17M | Buy |
44,688
+37,849
| +553% | +$2.67M | 0.02% | 677 |
|
|
2018
Q1 | $516K | Sell |
6,839
-3,783
| -36% | -$301K | ﹤0.01% | 1492 |
|
|
2017
Q4 | $761K | Buy |
+10,622
| New | +$807K | ﹤0.01% | 1525 |
|
|
2017
Q3 | – | Sell |
-6,249
| Closed | -$442K | – | 2439 |
|
|
2017
Q2 | $442K | Sell |
6,249
-8,086
| -56% | -$538K | ﹤0.01% | 1663 |
|
|
2017
Q1 | $974K | Sell |
14,335
-144,603
| -91% | -$10.2M | 0.01% | 1291 |
|
|
2016
Q4 | $11.4M | Buy |
158,938
+155,223
| +4,178% | +$11.5M | 0.06% | 301 |
|
|
2016
Q3 | $294K | Sell |
3,715
-170,335
| -98% | -$13.8M | ﹤0.01% | 1814 |
|
|
2016
Q2 | $14.5M | Buy |
174,050
+148,367
| +578% | +$13.2M | 0.07% | 191 |
|
|
2016
Q1 | $2.36M | Sell |
25,683
-10,871
| -30% | -$980K | 0.01% | 775 |
|
|
2015
Q4 | $3.7M | Buy |
36,554
+23,068
| +171% | +$2.4M | 0.02% | 587 |
|
|
2015
Q3 | $1.32M | Buy |
13,486
+8,677
| +180% | +$964K | 0.01% | 1091 |
|
|
2015
Q2 | $563K | Sell |
4,809
-16,712
| -78% | -$1.83M | ﹤0.01% | 1515 |
|
|
2015
Q1 | $2.11M | Buy |
21,521
+4,941
| +30% | +$502K | 0.01% | 746 |
|
|
2014
Q4 | $1.56M | Buy |
16,580
+10,806
| +187% | +$1.12M | 0.01% | 801 |
|
|
2014
Q3 | $615K | Buy |
5,774
+3,326
| +136% | +$326K | ﹤0.01% | 1237 |
|
|
2014
Q2 | $203K | Sell |
2,448
-45,157
| -95% | -$3.51M | ﹤0.01% | 1749 |
|
|
2014
Q1 | $3.37M | Buy |
47,605
+45,855
| +2,620% | +$3.6M | 0.03% | 425 |
|
|
2013
Q4 | $131K | Sell |
1,750
-5,409
| -76% | -$377K | ﹤0.01% | 1671 |
|
|
2013
Q3 | $450K | Sell |
7,159
-25,060
| -78% | -$1.5M | ﹤0.01% | 1242 |
|
|
2013
Q2 | $1.65M | Buy |
+32,219
| New | +$1.68M | 0.02% | 579 |
|
Other funds holding GILD
Jefferies Group's GILD Position: Q3 2022 in Review
Jefferies Group opened a new position in Gilead Sciences (GILD) in Q3 2022: 37,506 shares worth $2.31M. The stake represents 0.02% of the portfolio and ranks #555 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GILD as recently as Q1 2022.
Jefferies Group first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.9M in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Jefferies Group held 37,506 shares of Gilead Sciences worth $2.31M as of Q3 2022.
- Gilead Sciences was a new Jefferies Group position in Q3 2022.
- Gilead Sciences made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #555 holding.
- Jefferies Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's Gilead Sciences position peaked at $29.9M in Q4 2021.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.